223

SSX8 Antibody | 30-756

(No reviews yet) Write a Review
SKU:
223-30-756-GEN
$2,467.50

Description

SSX8 Antibody | 30-756 | Gentaur UK, US & Europe Distribution

Host: Rabbit

Reactivity: Human

Homology: N/A

Immunogen: Antibody produced in rabbits immunized with a synthetic peptide corresponding a region of human SSX8.

Research Area: Transcription

Tested Application: E, WB

Application: SSX8 antibody can be used for detection of SSX8 by ELISA at 1:312500. SSX8 antibody can be used for detection of SSX8 by western blot at 1 μg/mL, and HRP conjugated secondary antibody should be diluted 1:50, 000 - 100, 000.

Specificiy: N/A

Positive Control 1: Cat. No. XBL-10409 - Fetal Liver Tissue Lysate

Positive Control 2: N/A

Positive Control 3: N/A

Positive Control 4: N/A

Positive Control 5: N/A

Positive Control 6: N/A

Molecular Weight: 17 kDa

Validation: N/A

Isoform: N/A

Purification: Antibody is purified by peptide affinity chromatography method.

Clonality: Polyclonal

Clone: N/A

Isotype: N/A

Conjugate: Unconjugated

Physical State: Liquid

Buffer: Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose.

Concentration: batch dependent

Storage Condition: For short periods of storage (days) store at 4˚C. For longer periods of storage, store SSX8 antibody at -20˚C. As with any antibody avoid repeat freeze-thaw cycles.

Alternate Name: SSX8,

User Note: Optimal dilutions for each application to be determined by the researcher.

BACKGROUND: SSX8 belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneously humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy. SSX1, SSX2 and SSX4 genes have been involved in the t (X;18) translocation characteristically found in all synovial sarcomas.

View AllClose

Additional Information

Size:
100 uL
View AllClose